807 related articles for article (PubMed ID: 10394764)
1. Regulating research on the terminally ill: a proposal for heightened safeguards.
Addicott DC
J Contemp Health Law Policy; 1999; 15(2):479-524. PubMed ID: 10394764
[No Abstract] [Full Text] [Related]
2. An IRB member's perspective on access to innovative therapy.
Moore DL
Albany Law Rev; 1994; 57(3):559-81. PubMed ID: 11652854
[No Abstract] [Full Text] [Related]
3. Ethical and human-rights issues in research on mental disorders that may affect decision-making capacity.
Capron AM
N Engl J Med; 1999 May; 340(18):1430-4. PubMed ID: 10228198
[No Abstract] [Full Text] [Related]
4. An introduction to NBAC's report on research involving persons with mental disorders that may affect decisionmaking capacity.
Childress JF
Account Res; 1999; 7(2-4):101-15. PubMed ID: 11658169
[No Abstract] [Full Text] [Related]
5. Regulatory orphans: juvenile prisoners as transvulnerable research subjects.
Reed JG
IRB; 1999; 21(2):9-14. PubMed ID: 11657875
[No Abstract] [Full Text] [Related]
6. Informed consent to human subject research: improving the process of obtaining informed consent from mentally ill persons.
Derrickson D
Fordham Urban Law J; 1997; 25(1):143-65. PubMed ID: 12173638
[No Abstract] [Full Text] [Related]
7. Regulation of research on the decisionally impaired: history and gaps in the current regulatory system.
Moreno JD
J Health Care Law Policy; 1998; 1(1):1-21. PubMed ID: 15573427
[No Abstract] [Full Text] [Related]
8. Research involving the vulnerable sick.
Weijer C
Account Res; 1999; 7(1):21-36. PubMed ID: 11657560
[No Abstract] [Full Text] [Related]
9. Are research ethics bad for our mental health?
Michels R
N Engl J Med; 1999 May; 340(18):1427-30. PubMed ID: 10228197
[No Abstract] [Full Text] [Related]
10. Non-therapeutic medical research involving human subjects.
Bloom MJ
Syracuse Law Rev; 1973; 24():1067-1099. PubMed ID: 11664224
[No Abstract] [Full Text] [Related]
11. National commission proposes numerous new regulations of institutional review boards.
Maloney DM
Hum Res Rep; 1998 Oct; 13(10):1-2. PubMed ID: 11657739
[No Abstract] [Full Text] [Related]
12. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.
Weijer C
IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912
[No Abstract] [Full Text] [Related]
13. True protection for persons with severe mental disabilities, such as schizophrenia, involved as subjects in research? A look and consideration of the "Protection of Human Subjects.
Ryan AJ
J Law Health; 1994-1995; 9(2):349-76. PubMed ID: 11657417
[No Abstract] [Full Text] [Related]
14. Demarcating research and treatment: a systematic approach for the analysis of the ethics of clinical research.
Freedman B; Fuks A; Weijer C
Clin Res; 1992 Dec; 40(4):653-60. PubMed ID: 1486732
[No Abstract] [Full Text] [Related]
15. Institutional review boards (IRBs) failed to use steps to protect vulnerable research subjects.
Maloney DM
Hum Res Rep; 2003 Jun; 18(6):6-7. PubMed ID: 15119342
[No Abstract] [Full Text] [Related]
16. 1931 German guidelines on human experimentation.
Int Dig Health Legis; 1980; 31(2):408-11. PubMed ID: 11645672
[No Abstract] [Full Text] [Related]
17. Protection of human subjects.
U.S. Department of Health and Human Services
Code Fed Regul Public Welfare; 1995 Oct; Title 45(Sections 46-101 to 46-409):. PubMed ID: 11686173
[No Abstract] [Full Text] [Related]
18. The changing clinical trials scene: the role of the IRB.
Mitchell SC; Steingrub J
IRB; 1988; 10(4):1-5. PubMed ID: 11650078
[No Abstract] [Full Text] [Related]
19. Human experimentation. Protecting patient autonomy through informed consent.
Tuthill KA
J Leg Med; 1997 Jun; 18(2):221-50. PubMed ID: 9230568
[No Abstract] [Full Text] [Related]
20. Regulating research with vulnerable populations: litigation gone awry.
Oldham JM; Haimowitz S; Delano SJ
J Health Care Law Policy; 1998; 1(1):154-73. PubMed ID: 15573435
[No Abstract] [Full Text] [Related]
[Next] [New Search]
